Great Debates in Oncology: The Use of Adjuvant/ Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma - Round 3
In the 3rd and final round of Great Debates in Oncology: The Use of Adjuvant/Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma, moderated by Brian Van Tine, MD, PhD, experts Jonathan Trent, MD, PhD, and Robin Jones, BSc, MB BS, MRCP, MD (Res), debate about which patient characteristics to consider when determining the appropriateness of adjuvant/neoadjuvant chemotherapy for localized soft-tissue sarcoma.
Listen to round 3 below or read the comments.
In case you missed it, listen to round 2, where Dr Trent and Dr Jones went head-to-head on whether the benefits of adjuvant/neoadjuvant chemotherapy outweigh the associated toxicities.
Check out the Great Debates in Oncology: The Use of Adjuvant and Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma page to listen to the entire series and cast your votes!
